Neuroblastoma, a nerve cancer, primarily affects young children. The tumor originates from the immature nerve cells. It is one of the most common extracranial solid tumors seen in pediatric patients. Oncologists should determine the type of neuroblastoma for treatment optimization and prognosis prediction.
Neuroblastoma cancer occurs in immature nerve cells that are commonly found in a fetus or embryo. These immature nerve cells are known as neuroblasts and are involved in nervous system development. Neuroblastoma cancer occurs most often in young children and infants (≤5 years of age). This cancer most frequently affects the adrenal glands (glands above the kidneys). The other sites for neuroblastoma development include the abdomen, neck, chest, and spinal cord. The symptoms range from a benign, palpable mass to serious complications due to the spread of the tumor.
Neuroblastoma cancer constitutes about 8 - 12% of all childhood cancer cases. The rate of neuroblastoma incidence is about 11 to 13 per million in children <15 years of age. The incidence rate varies according to age. It is 1 per million in children between 10 and 14 years of age and 65 per million in children below the age of 1 year.
Some of the common types of neuroblastoma cancer are:
Following are the different neuroblastoma stages:
Neuroblastoma is a cancer that originates from immature nerve cells. It is one of the most common childhood cancers and occurs often in children less than five years old. There are several methods to determine types of neuroblastoma cancer. One classification is based on the spread of the disease. These include localized, regional, and metastatic neuroblastomas. The other classification is based on histopathological characteristics and sequential chromosome aberrations. The stages of neuroblastoma range from stage 1 to stage 4.